Recommendations when to order or not order the test. May include related or preferred tests.
For use in individuals with symptoms of cystic fibrosis (CF) or a CFTR-related disorder. This test is NOT indicated for routine carrier screening; refer to Cystic Fibrosis (CFTR) Expanded Variant Panel (2013661).
Unique test identifier.
Process(es) used to perform the test.
Massively Parallel Sequencing/Sequencing
Days of the week the test is performed.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Lavender or pink (EDTA) or yellow (ACD solution A or B). New York State Clients: Lavender or pink (EDTA).
Transport 3 mL whole blood. (Min: 2 mL)
Serum or plasma; grossly hemolyzed or frozen specimens; saliva, buccal brush, or swab; FFPE tissue.
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA-certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Other names that describe the test. Synonyms.
Cystic Fibrosis (CFTR) Sequencing and Deletion/Duplication